Pharma

Breakthrough in cardiac pharmacology

PhysioStim of France, a specialist in cardiac safety pharmacology, is setting up a new model for isolated cardiomyocytes, which will record all types of ionic currents and action potentials. This model will provide an overview of cardiac physiological mechanisms, drawn up at cellular level. Testing to detect any possible risk of cardiac toxicity induced by pharmaceuticals is crucial during the preclinical R&D stage. PhysioStim has solid and reliable expertise in this highly specialised area, particularly with hERG assays

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top